Detalhe da pesquisa
1.
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.
Invest New Drugs
; 35(5): 616-626, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28194539
2.
Pharmacokinetic study of aldoxorubicin in patients with solid tumors.
Invest New Drugs
; 33(2): 341-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25388939
3.
Safety and Efficacy Outcomes From a Single-Center Study of Image-Guided Percutaneous Microwave Ablation for Primary and Metastatic Lung Malignancy.
JTO Clin Res Rep
; 4(2): 100454, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36846573
4.
Low booster uptake in cancer patients despite health benefits.
medRxiv
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961284
5.
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.
Oncotarget
; 13: 1202-1214, 2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342462
6.
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).
BJU Int
; 108(5): 693-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21105991
7.
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).
Clin Lung Cancer
; 22(4): 301-312.e8, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33775558
8.
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
Clin Cancer Res
; 15(10): 3600-9, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447868
9.
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.
J Clin Oncol
; 38(6): 538-547, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809241
10.
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 6(5): 661-674, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32271377
11.
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.
Clin Cancer Res
; 13(20): 6175-81, 2007 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947484
12.
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.
Clin Cancer Res
; 24(12): 2749-2757, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559563
13.
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
J Thorac Oncol
; 13(2): 165-183, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175116
14.
EGFR Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an EGFR Tyrosine Kinase Inhibitor.
JCO Precis Oncol
; 2: 1-13, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135111
15.
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Clin Lung Cancer
; 19(4): 331-339, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773328
16.
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
N Engl J Med
; 349(9): 859-66, 2003 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12944571
17.
Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers.
Lung Cancer
; 112: 195-199, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191595
18.
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 18(5): 480-488, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28365238
19.
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
Lancet Respir Med
; 5(11): 891-902, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29056570
20.
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.
J Clin Oncol
; 23(11): 2534-43, 2005 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15699478